| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.28B | -3.4% | -6.7% |
| R&D Expense | $6.0M | +0.0% | +0.0% |
| SG&A Expense | $536.9M | -0.6% | -0.7% |
| Operating Income | -$16.17B | -9231.3% | — |
| Pre-tax Income | -$16.52B | -4459.6% | -6292.9% |
| Income Tax | -$4.06B | -4442.6% | -8356.5% |
| Net Income | -$12.47B | -4464.8% | -5822.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.12B | +34.8% | +195.6% |
| Short-term Investments | $61K | +0.0% | -64.5% |
| Accounts Receivable | $824.6M | -3.6% | -4.0% |
| Inventory | $225.1M | +14.6% | -16.2% |
| Current Assets | $2.62B | -6.8% | -37.2% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $155.1M | — | — |
| Capital Expenditures | $687.1M | — | — |
| Investing Cash Flow | -$1.22B | — | — |
| Financing Cash Flow | $1.66B | — | — |
| Free Cash Flow | -$532.0M | — | — |
| $30.71B |
| -30.8% |
| -32.6% |
| Current Liabilities | $8.04B | +52.5% | +10.3% |
| Long-term Debt | $20.47B | -6.9% | — |
| Total Liabilities | $38.21B | -3.0% | -13.7% |
| Stockholders' Equity | -$7.94B | -275.8% | -1028.5% |